A slightly elevated plasma free metanephrine with normal 24-hour urine metanephrines is likely a false positive and generally not concerning, but requires careful interpretation based on the degree of elevation and clinical context.
The most important factor is whether your plasma metanephrine elevation is less than 2-fold above the upper limit of normal—if so, this strongly suggests a false positive result rather than pheochromocytoma. 1
Understanding the Discordance
The discordance between your plasma and urine results is actually quite common and typically favors the urine test being correct. Here's why:
- Plasma metanephrines have higher sensitivity (up to 99%) but lower specificity compared to 24-hour urine metanephrines 1
- 24-hour urine metanephrines have excellent sensitivity (90-95%) with better specificity 1
- Recent research shows plasma tests yield significantly more false positives than urine tests, particularly when blood is drawn in the seated position 2
Key Factors That Cause False-Positive Plasma Results
According to Hypertension Canada 2020 guidelines, false-positive plasma metanephrines should be suspected when you have 1:
- Mild elevation (less than 2-fold the upper limit) ← This is your most important clue
- Only 1 abnormal test in the panel (your urine is normal)
- Low pretest probability of pheochromocytoma (no classic symptoms)
- Incorrect patient positioning during blood draw (seated vs. supine)
- Interfering medications
- Acute illness or hospitalization
Medication Interference
Norepinephrine reuptake blockers (like certain antidepressants) are the most common medication cause of falsely elevated plasma normetanephrine, and can also elevate metanephrine 3. Other interfering drugs include tricyclic antidepressants, decongestants, and amphetamines 4.
Sampling Conditions Matter
If your blood was drawn while seated rather than after 30 minutes lying down, this significantly increases false-positive rates 5, 6. Studies show plasma tests in seated patients have 75.6% specificity compared to 94.2% for urine tests 6.
What You Should Do Next
Based on the 2020 Hypertension Canada guidelines 1:
Repeat plasma metanephrines with proper technique: Blood drawn after 30 minutes supine rest, using age-appropriate reference ranges 5
Consider a clonidine suppression test if repeat testing remains borderline elevated—this has 97% sensitivity and 100% specificity for distinguishing true from false positives 1, 5
Do NOT proceed to imaging before biochemical confirmation—this avoids identifying incidental adrenal findings unrelated to pheochromocytoma 1
Review all medications for potential interference, particularly antidepressants and decongestants 3
Clinical Context Matters
The pretest probability of pheochromocytoma is extremely low (0.2-0.4% of hypertensive patients) 7. Classic symptoms that would increase concern include:
- Severe paroxysmal hypertension with headaches, sweating, palpitations, and pallor
- Unexplained weight loss
- Anxiety attacks
- Family history of pheochromocytoma or associated syndromes (MEN2, von Hippel-Lindau, neurofibromatosis)
Without these symptoms and with normal urine metanephrines, the likelihood of true pheochromocytoma is very low.
Important Caveats
While generally reassuring, there are rare exceptions:
- **Very small pheochromocytomas (<2 cm) can occasionally present with normal or borderline urine metanephrines** but significantly elevated plasma levels (>2-fold) 8
- If you have a lipid-poor adrenal incidentaloma on imaging, this changes the pretest probability and warrants more aggressive workup 8
- Obstructive sleep apnea, obesity, and family history of hypertension increase false-positive urine results specifically 2
Bottom Line
Your normal 24-hour urine metanephrines are highly reassuring. The slightly elevated plasma result most likely represents a false positive, especially if less than 2-fold elevated, drawn seated, or in the setting of interfering medications. Repeat testing with proper technique is reasonable, but imaging and aggressive workup are not warranted at this stage unless repeat testing shows values ≥2-fold elevated or you develop concerning symptoms.